Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels
- 13 November 2008
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hepatology
- Vol. 49 (2), 697
- https://doi.org/10.1002/hep.22691
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetesJournal of Hepatology, 2008
- Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitisWorld Journal of Gastroenterology, 2007
- In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver diseaseJournal of Hepatology, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseJournal of Hepatology, 2005